CTRP4 deficiency promotes the development of atherosclerosis in ApoE<sup>‒/‒</sup> mice, whereas CTRP4 supplementation attenuates atherosclerosis via binding and inhibition of RAGE and TLR4. Here, C1QTNF4 is linked to atherosclerosis.